Document Detail


Effect of endotoxin shock on the clearance of lidocaine and indocyanine green in the perfused rat liver.
MedLine Citation:
PMID:  10588516     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Endotoxin administration and cecal ligation and puncture produce significant hepatocellular dysfunction when studied in vivo. Specific factors that are present in vivo after endotoxin administration and cecal ligation and puncture, such as alterations in liver blood flow, circulating mediators, and hypoxia, can alter hepatic function. In this study, we used an isolated perfused liver to evaluate the effects of in vivo administration of endotoxin on hepatic function using indocyanine green (ICG) as a global marker of function and lidocaine and its metabolite, MEGX, as specific markers of the CYP450 enzyme system. Endotoxin (Escherichia coli; 45 mg/kg i.p.) was administered to rats followed by a 6-h monitoring before preparation of the isolated in situ perfused liver. Livers from control and endotoxin groups received either ICG (control, n = 6; endotoxin, n = 5) or lidocaine (control, n = 8; endotoxin, n = 8). A separate group of rats (n = 6) received cimetidine (an inhibitor of the CYP450 enzyme system) at a dose of 80 mg/kg daily for 3 days. Livers were perfused via the portal vein by using a single-pass system with a balanced salt solution 6 h after receiving either endotoxin or saline or 24 h after receiving the last dose of cimetidine. After a 40-min stabilization period, ICG or lidocaine was infused via the portal vein until steady-state concentrations were reached in the venous outflow. The total hepatic clearance and intrinsic hepatic clearance for ICG and lidocaine were unchanged in the livers obtained from endotoxin-treated rats. This model could adequately detect CYP450 inhibition because cimetidine-treated rats had significantly lower initial MEGX concentrations (0.63 +/- 0.03 mg/L) compared with control (0.77 +/- 0.03 mg/L) and endotoxin-treated (0.74 +/- 0.04 mg/L) rats. Septic livers had significantly higher initial hepatic oxygen consumption (HVO2) than did control livers (45 +/- 3 microL/min/g vs 82 +/- 9 microL/min/g). The HVO2 remained higher in the septic livers and significantly increased throughout the study, which demonstrated that the livers remained viable and functional. These data indicate that there is no detectable hepatocellular dysfunction after endotoxin shock using ICG, lidocaine, and MEGX in the isolated perfused liver; therefore the dysfunction reported from in vivo studies may be reversible when the liver is removed from the shocked environment.
Authors:
D S McKindley; C Chichester; R Raymond
Related Documents :
17394146 - Preservation of steatotic livers: a comparison between cold storage and machine perfusi...
519106 - Prostaglandins and the contractile action of bradykinin on the longitudinal muscle of r...
6153276 - Net biosynthesis of antithrombin iii by the isolated rat liver perfused for 12--24 hour...
12143046 - Bioactivation of nitroglycerin and vasomotor response to nitric oxide are impaired in c...
1151786 - Sugar absorption by foetal and neonatal rat intestine in vitro.
18937286 - Spatiotemporal characteristics of astroglial death in the rat hippocampo-entorhinal com...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Shock (Augusta, Ga.)     Volume:  12     ISSN:  1073-2322     ISO Abbreviation:  Shock     Publication Date:  1999 Dec 
Date Detail:
Created Date:  2000-01-11     Completed Date:  2000-01-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9421564     Medline TA:  Shock     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  468-72     Citation Subset:  IM    
Affiliation:
University of Rhode Island, College of Pharmacy, Kingston 02881, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anesthetics, Local / pharmacokinetics*
Animals
Cimetidine / pharmacology
Coloring Agents / pharmacokinetics*
Cytochrome P-450 Enzyme System / antagonists & inhibitors,  metabolism
Endotoxins / toxicity
Enzyme Inhibitors / pharmacology
Indocyanine Green / pharmacokinetics*
Isoenzymes / antagonists & inhibitors,  metabolism
Lidocaine / analogs & derivatives,  analysis,  pharmacokinetics*
Liver / metabolism*
Male
Metabolic Clearance Rate
Oxygen Consumption
Perfusion
Rats
Rats, Sprague-Dawley
Shock, Septic / metabolism*
Chemical
Reg. No./Substance:
0/Anesthetics, Local; 0/Coloring Agents; 0/Endotoxins; 0/Enzyme Inhibitors; 0/Isoenzymes; 137-58-6/Lidocaine; 3599-32-4/Indocyanine Green; 51481-61-9/Cimetidine; 7728-40-7/monoethylglycinexylidide; 9035-51-2/Cytochrome P-450 Enzyme System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neutrophil elastase inhibitor (ONO-5046) attenuates reperfusion-induced hepatic microcirculatory der...
Next Document:  The effects of two new antagonists of secretory PLA2 on TNF, iNOS, and COX-2 expression in activated...